Skip to main content

Table 1 Characteristics of included studies

From: A systematic review of tools for predicting severe adverse events following patient discharge from intensive care units

Study

Year

Country

Follow-up

Type of ICU

# Patients

Age (Mean)

Female (%)

Severity of Illness score (Mean)

Readmission

No. (%)ε

Mortality

No. (%)ζ

Gajic

2008

USA, Netherlands

7 days

Medical-Surgical

2,622

64µ

46µ

APACHE III (59)µ

217 (8.3)

5 (0.4)µ

Frost

2010

Australia

Hospital discharge

Medical-Surgical

14,952

57

39

APACHE II (13)

896 (6.0)

869 (6.0)

Reini

2012

Sweden

Hospital discharge

Medical-Surgical

518

59

46

SAPS III (55)

13 (3.7)

29 (8.8)

Badawi

2012

USA

48 hours

Mixed§

704,963

62

46

APACHE IV (47β)

17,874 (2.5)

6,492 (0.9)

Daly

2001

UK

Hospital discharge

Medical-Surgical

13,924

67-72γ

36

APACHE II (13)

142 (2.6)µ

1,158 (8.3)

Fernandez

2006

Spain

Hospital discharge

Medical-Surgical

1,159

60

N/A

APACHE II (20)†

N/A

111 (9.6)

Fernandez

2010

Spain

Hospital discharge

Medical-Surgical

3,587

61

33

N/A

190 (5.3)

242 (6.7)α

Ouanes

2012

France

7 days

Medical-Surgical

3,462

61

38

SAPS II (35)

74 (2.1)

28 (0.8)

  1. APACHE, Acute Physiology and Chronic Health Evaluation; ICU, Intensive Care unit; N/A, Not Available; SAPS, Simplified Acute Physiology Score; UK, United Kingdom; USA, United States of America.
  2. ε Readmission to ICU following patient discharge from ICU.
  3. ζ Hospital mortality following patient discharge form ICU.
  4. µ Data from derivation cohort.
  5. § Mixed ICUs: Medical, Medical-Surgical, Surgical, Trauma, Neurological, Cardiac, Cardiovascular.
  6. β Median value.
  7. γ Range of median ages for the derivation and validation cohorts.
  8. † Point score estimated from predicted risk of death (percentage).
  9. α Sensitivity analyses restricted to unexpected deaths produced the same mortality percentage.